Elanco Animal Health 

€21.2
51
+€0+0% Thursday 13:48

Statistics

Day High
21.2
Day Low
21.2
52W High
-
52W Low
-
Volume
80
Avg. Volume
-
Mkt Cap
10.53B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

24FebExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
0.11
0.2
0.28
0.37
Expected EPS
0.11346
Actual EPS
N/A

Financials

7.47%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
8.42BRevenue
628.58MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 5EA.XETRA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap63.86B
Zoetis is a global leader in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines, directly competing with Elanco in both the companion and livestock animal product markets.
Merck
MRK
Mkt Cap214.76B
Merck & Co., through its animal health division, offers veterinary pharmaceuticals, vaccines, and health management solutions and services, making it a direct competitor to Elanco in multiple segments of the animal health industry.
Phibro Animal Health
PAHC
Mkt Cap1.76B
Phibro Animal Health Corporation operates in the animal health and mineral nutrition markets, offering medicated feed additives, which puts it in direct competition with Elanco's product offerings.
Idexx Laboratories
IDXX
Mkt Cap50.36B
IDEXX Laboratories, Inc. provides diagnostic, detection, and information systems for veterinary, livestock, and poultry services, competing with Elanco in the animal health diagnostics market.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories, through its animal health division (before divestiture), offered products that competed with Elanco in diagnostics and nutrition, although its focus has shifted, it remains a competitor through legacy products and technologies.
Pfizer
PFE
Mkt Cap140.15B
Pfizer, prior to the spin-off of its animal health division into Zoetis, was a direct competitor in the development and commercialization of animal health products, and it maintains a presence in the market through ongoing investments and partnerships.
Elia Group SA/NV
ELI.BR
Mkt Cap11.6B
Elia System Operator provides infrastructure and services for the energy sector but is included erroneously as it does not compete in the animal health sector, illustrating the importance of accurate industry classification.

About

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Show more...
CEO
Mr. Jeffrey N. Simmons
Employees
9000
Country
US
ISIN
US28414H1032
WKN
000A2N6BH

Listings

0 Comments

Share your thoughts

FAQ

What is Elanco Animal Health stock price today?
The current price of 5EA.XETRA is €21.2 EUR — it has increased by +0% in the past 24 hours. Watch Elanco Animal Health stock price performance more closely on the chart.
What is Elanco Animal Health stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Elanco Animal Health stocks are traded under the ticker 5EA.XETRA.
What is Elanco Animal Health market cap?
Today Elanco Animal Health has the market capitalization of 10.53B
When is the next Elanco Animal Health earnings date?
Elanco Animal Health is going to release the next earnings report on February 24, 2026.
What were Elanco Animal Health earnings last quarter?
5EA.XETRA earnings for the last quarter are 0.17 EUR per share, whereas the estimation was 0.11 EUR resulting in a +46.16% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Elanco Animal Health revenue for the last year?
Elanco Animal Health revenue for the last year amounts to 8.42B EUR.
What is Elanco Animal Health net income for the last year?
5EA.XETRA net income for the last year is 628.58M EUR.
How many employees does Elanco Animal Health have?
As of February 12, 2026, the company has 9,000 employees.
In which sector is Elanco Animal Health located?
Elanco Animal Health operates in the Health Care sector.
When did Elanco Animal Health complete a stock split?
Elanco Animal Health has not had any recent stock splits.
Where is Elanco Animal Health headquartered?
Elanco Animal Health is headquartered in Greenfield, US.